FDA Reports 16% Increase in Antimicrobial Sales for Food-Producing Animals in 2024

The FDA’s Center for Veterinary Medicine (CVM) has released new data showing a 16% increase in U.S. sales and distribution of medically important antimicrobials for food-producing animals between 2023 and 2024.
These hogs are getting ready for market as they grow inside this Iowa swine finishing barn.
  • Medically important antimicrobial sales rose 16% from 2023 to 2024.
  • Sales remain 27% below the all-time high recorded in 2015.
  • Data include sales and distribution volumes reported by animal drug sponsors to the FDA.
  • The agency emphasized that sales do not necessarily reflect actual use in animals.
  • Interactive dashboards now provide greater transparency through species, drug class, and year filters.
  • Biomass-adjusted data available to help interpret antimicrobial sales relative to animal populations.

Understanding the 2024 Findings

The FDA’s report reflects data required under the Federal Food, Drug, and Cosmetic Act, which mandates annual reporting of antimicrobial sales and distribution by drug sponsors. The 2024 results represent a departure from the relatively stable trend observed since 2017.

Sales fluctuations, according to the FDA, may occur due to changes in animal populations, health conditions, or production practices. The agency clarified that the data captures sales volume, not actual antimicrobial use.

Enhanced Data Access and Visualization

For 2024, the FDA expanded public access to the data through a dashboard-based reporting format, allowing users to visualize antimicrobial sales across variables such as drug class, livestock species, and year.

The report also includes biomass-adjusted data, which normalize antimicrobial sales relative to the size of the treated animal population. This approach provides a more accurate understanding of antimicrobial distribution trends in U.S. livestock.

Supporting Stewardship and Resistance Mitigation

The FDA continues its efforts to combat antimicrobial resistance and promote judicious antimicrobial use in veterinary settings. The agency provides guidance, Q&A resources, and stewardship initiatives to support data-driven policy and responsible prescribing practices.

Additional Resources

Information sourced from the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) press release.